Cite

HARVARD Citation

    Quagliariello, V. et al. (2019). Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab. International journal of cardiology. pp. 171-179. [Online]. 
  
Back to record